High level of anticholesterol antibodies (ACHA) in HIV patients. Normalization of serum ACHA concentration after introduction of HAART

Immunobiology

Volumn 203, Issue 5, 2001, Pages 756-768

  Horvath A ^a   Banhegyi D ^b   Biro A ^a   Ujhelyi, E ^b   Veres, A ^a   Horvath L ^a   Prohaszka Z ^a   Bacsi A ^c   Tarjan V ^d   Romics, L ^a   Horvath I ^e   Toݩth, F D ^c   Fuݶst, G ^a   Karadi I ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Szent Laszlo Hospital   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

^d National Blood Transfusion Service   (Hungary)

^e Natl Inst Dermatol and Venerology   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AUTOANTIBODY; CHOLESTEROL ANTIBODY; HEAT SHOCK PROTEIN 60; HYDROXYL GROUP; IMMUNOGLOBULIN G; INDINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION FUNCTION; DOSE RESPONSE; DRUG THERAPY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPOCHOLESTEROLEMIA; INCUBATION TIME; MALE; PRIORITY JOURNAL;

EID: 0034866831     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(01)80004-8     Document Type: Article

References (35)

1. Interactions of anti-cholesterol antibodies with human lipoproteins
2. Naturally occurring autoantibodies to cholesterol in humans
3. Antibodies to cholesterol, cholesterol conjugates and liposomes: Implications for atherosclerosis and autoimmunity
4. Immunization with cholesterol-rich liposomes induces anti-cholesterol antibodies and reduces diet-induce hypercholesterolaemia and plaque formation
5. Influence of cholesterol liposome immunization and immunostimulation on rabbits atherosclerosis induced by a high cholesterol diet
6. Antibodies against cholesterol (ACHA) in patients with different atherosclerotic vascular diseases and healthy individuals. Characterization of human ACHA
7. Hypertriglyceridemia in the acquired immunodeficiency syndrome
8. Lipids, lipoproteins, triglyceride clearance and cytokines in human immunodeficiency syndrome
9. The hypertrigliceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B
10. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease
11. Buffalo hump in men with HIV-1 infection
12. Visceral abdominal-fat accumulation associated with use of indinavir
13. A syndrome of peripheral lipodystrophy, hyperlipidemia ans isulin resistance in patients receiving HIV protease inhibitors
14. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients
15. Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects
16. Fat distribution and metabolic changes in patients with HIV infection
17. Naturally occurring antibodies to cholesterol: A new theory of LDL cholesterol metabolism
18. Cholesterol sulphate-reacting autoantibodies are specifically increased in chronic chagasic patients
19. Detection, isolation and continous production of cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS
20. The role of mononuclear phagocytes in HTLVIII/LAV infection
21. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions
22. Antibodies against human hsp60 and mycobacterial hsp65 differ in their antigen specificity and complement activating ability
23. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: Comparison of phospholipid specificity, avidity and reactivity with beta2-GPI
24. Anti-cardiolipin antibodies are associated with anti-endothelial cell antibodies but not with anti-beta2 glycoprotein I antibodies in HIV infection
25. Antiphospholipid antibodies in children
26. Recognition of defined epitopes by affinity-purified anti-immunoglobulin fab antibodies isolated from HIV-infected humans
27. Analysis of autoantibodies to T-cell receptors among HIV-infected individuals: Epitope analysis and time course
28. Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function
29. Does AIDS emerge from a disequilibrium between two complementary groups of molecules that mimic MHC?
30. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts
31. Influence of protease inhibitor therapy on lipoprotein metabolism
32. Apoliporotein A and biological half-life of prostaglandin I2 in HIV-1 infection
33. Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection
34. Lipoprotein alterations in patients with HIV infection: Relation with cellular and humoral immune markers
35. Plasma lipids in HIV-infected patients: A prospective study in 95 patients